@CNN: Genetic testing company 23andMe has been give federal approval to sell at-home kits that test for three breast cancer gene mutations https://t.co/6yBLXbVtek https://t.co/l8dwUEOLNj
Genetic testing company 23andMe has been give federal approval to sell at-home kits that test for three breast cancer gene mutations https://t.co/6yBLXbVtek pic.twitter.com/l8dwUEOLNj
— CNN (@CNN) March 7, 2018